DAFNA Capital Management LLC
Position in BCAX — Bicara Therapeutics Inc.
CIK 1389933
LOS ANGELES, CA
Position in BCAX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,388,269
+$3,985,828 QoQ
Shares Held
421,733
+61.2% QoQ
Ownership
0.642%
of shares outstanding
% of Portfolio
2.15%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BCAX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DAFNA Capital Management LLC holds $266,800,868 across 59 Biotechnology names. BCAX ranks #9 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
580,678 | $56,470,935 | |
| 2 | DAWN |
Day One Biopharmaceuticals, Inc.
|
978,463 | $20,978,246 | |
| 3 | IDYA |
IDEAYA Biosciences, Inc.
|
476,740 | $15,884,976 | |
| 4 | XENE |
Xenon Pharmaceuticals Inc.
|
250,772 | $14,582,391 | |
| 5 | CYTK |
Cytokinetics Inc
|
217,497 | $14,335,227 | |
| 6 | NKTR |
Nektar Therapeutics
|
165,178 | $11,884,557 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
443,829 | $9,586,706 | |
| 8 | LRMR |
Larimar Therapeutics, Inc.
|
2,029,164 | $9,131,238 |
All Filings in BCAX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,388,269 | 421,733 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $4,402,441 | 261,583 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $5,005,445 | 317,001 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,944,939 | 317,001 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,762,373 | 212,001 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,837,810 | 105,500 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||